Public Sector Pension Investment Board cut its holdings in shares of Cardiovascular Systems Inc (NASDAQ:CSII) by 11.9% during the fourth quarter, HoldingsChannel.com reports. The fund owned 78,880 shares of the medical device company’s stock after selling 10,700 shares during the period. Public Sector Pension Investment Board’s holdings in Cardiovascular Systems were worth $3,833,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also bought and sold shares of the company. Quadrant Capital Group LLC boosted its holdings in Cardiovascular Systems by 57.0% in the 4th quarter. Quadrant Capital Group LLC now owns 1,631 shares of the medical device company’s stock valued at $78,000 after purchasing an additional 592 shares during the last quarter. NumerixS Investment Technologies Inc increased its stake in Cardiovascular Systems by 900.0% during the 4th quarter. NumerixS Investment Technologies Inc now owns 2,000 shares of the medical device company’s stock worth $97,000 after buying an additional 1,800 shares during the period. Exchange Traded Concepts LLC purchased a new stake in Cardiovascular Systems during the 4th quarter worth approximately $98,000. Aigen Investment Management LP purchased a new stake in Cardiovascular Systems during the 4th quarter worth approximately $202,000. Finally, Quantbot Technologies LP purchased a new stake in Cardiovascular Systems during the 4th quarter worth approximately $246,000. Hedge funds and other institutional investors own 90.50% of the company’s stock.
CSII traded up $1.72 during trading hours on Thursday, hitting $34.65. 29,867 shares of the company’s stock were exchanged, compared to its average volume of 407,169. Cardiovascular Systems Inc has a 12-month low of $26.00 and a 12-month high of $55.22. The firm has a 50 day moving average of $37.98 and a 200 day moving average of $44.93. The company has a current ratio of 3.18, a quick ratio of 2.78 and a debt-to-equity ratio of 0.15. The firm has a market cap of $1.17 billion, a P/E ratio of -164.71 and a beta of 1.76.
Cardiovascular Systems (NASDAQ:CSII) last issued its quarterly earnings results on Wednesday, February 5th. The medical device company reported ($0.10) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.03) by ($0.07). Cardiovascular Systems had a negative return on equity of 4.90% and a negative net margin of 2.66%. The business had revenue of $68.33 million for the quarter, compared to analyst estimates of $67.90 million. As a group, research analysts expect that Cardiovascular Systems Inc will post -0.19 EPS for the current fiscal year.
Several brokerages recently weighed in on CSII. ValuEngine raised shares of Cardiovascular Systems from a “hold” rating to a “buy” rating in a research note on Wednesday, March 4th. Zacks Investment Research raised shares of Cardiovascular Systems from a “strong sell” rating to a “hold” rating and set a $43.00 target price on the stock in a research note on Monday, January 13th. BidaskClub downgraded shares of Cardiovascular Systems from a “hold” rating to a “sell” rating in a research note on Tuesday, March 17th. Finally, TheStreet downgraded shares of Cardiovascular Systems from a “c-” rating to a “d+” rating in a research note on Friday, March 13th. Two investment analysts have rated the stock with a sell rating, three have given a hold rating and three have given a buy rating to the stock. The stock presently has an average rating of “Hold” and an average target price of $49.60.
About Cardiovascular Systems
Cardiovascular Systems, Inc, a medical device company, develops, manufactures, and commercializes various devices to treat vascular and coronary diseases in the United States. The company offers peripheral arterial disease products, including Diamondback 360 Peripheral, Predator 360, Stealth 360 Peripheral Orbital Atherectomy System (OAS), Diamondback 360 60cm Peripheral OAS, Diamondback 360 Low Profile Peripheral, Diamondback 360 1.50 Peripheral, Diamondback 360 2.00 Peripheral, Diamondback 360 200cm Peripheral, and Diamondback 360 180cm Peripheral, which are catheter-based platforms for treating a range of plaque types in leg arteries above and below the knee, including calcified plaque, as well as address various limitations associated with surgical, catheter, and pharmacological treatment alternatives.
Further Reading: Understanding the different types of bonds
Want to see what other hedge funds are holding CSII? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardiovascular Systems Inc (NASDAQ:CSII).
Receive News & Ratings for Cardiovascular Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiovascular Systems and related companies with MarketBeat.com's FREE daily email newsletter.